Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Allegheny Health Network (AHN) Neuroscience Institute is a comprehensive clinical and research center dedicated to the treatment of complex neurological and neurosurgical conditions. Based in Pittsburgh, Pennsylvania, the institute is a leader in the application of deep brain stimulation (DBS) for movement disorders and psychiatric conditions. It operates specialized centers for stroke, epilepsy, and neuro-oncology, utilizing advanced technologies such as Gamma Knife radiosurgery and minimally invasive robotic spine surgery. As a significant research hub, the institute conducts numerous clinical trials in collaboration with pharmaceutical and medical device partners to advance therapies for Alzheimer's, ALS, and chronic pain. The institute integrates multidisciplinary care with academic rigor through its affiliation with the Drexel University College of Medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allegheny Health Network Neuroscience Institute.